PL2361303T3 - Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki - Google Patents

Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki

Info

Publication number
PL2361303T3
PL2361303T3 PL09744160.4T PL09744160T PL2361303T3 PL 2361303 T3 PL2361303 T3 PL 2361303T3 PL 09744160 T PL09744160 T PL 09744160T PL 2361303 T3 PL2361303 T3 PL 2361303T3
Authority
PL
Poland
Prior art keywords
hgl
msc
kidney
preparing
stem cell
Prior art date
Application number
PL09744160.4T
Other languages
English (en)
Polish (pl)
Inventor
Giovanni Camussi
Stefania Bruno
Benedetta Bussolati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2361303T3 publication Critical patent/PL2361303T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0687—Renal stem cells; Renal progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09744160.4T 2008-11-04 2009-11-02 Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki PL2361303T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08425708A EP2186883A1 (en) 2008-11-04 2008-11-04 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney

Publications (1)

Publication Number Publication Date
PL2361303T3 true PL2361303T3 (pl) 2016-10-31

Family

ID=40260686

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09744160.4T PL2361303T3 (pl) 2008-11-04 2009-11-02 Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki

Country Status (7)

Country Link
US (1) US9499796B2 (enExample)
EP (2) EP2186883A1 (enExample)
JP (1) JP5795737B2 (enExample)
CN (1) CN102292434B (enExample)
ES (1) ES2580172T3 (enExample)
PL (1) PL2361303T3 (enExample)
WO (1) WO2010052192A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
TWI542690B (zh) 2010-05-12 2016-07-21 再生醫學Ｔｘ有限責任公司 生物活性腎細胞
ES2974955T3 (es) * 2010-08-31 2024-07-02 Gallant Pet Inc Terapias sistémicas con células madre alogénicas para el tratamiento de enfermedades en perros y gatos
CN103261407B (zh) * 2010-12-22 2016-03-02 杜兰教育基金委员会 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法
PL2729562T3 (pl) 2011-07-06 2018-10-31 Cell Therapy Limited Komórki progenitorowe pochodzenia mezodermalnego
WO2013049856A2 (en) * 2011-09-30 2013-04-04 Hare Joshue M Renal stem cells isolated from kidney
KR102674303B1 (ko) 2012-10-24 2024-06-12 인리젠 신장 세포 모집단 및 이의 용도
WO2014113704A2 (en) 2013-01-18 2014-07-24 Escape Therapeutics, Inc. Enhanced differentiation of mesenchymal stem cells
CN104977414B (zh) * 2014-04-09 2016-09-28 上海交通大学医学院 鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用
EP3184627B1 (en) * 2014-08-21 2020-12-23 Ajinomoto Co., Inc. Culture medium for mesenchymal stem cells
TWI689589B (zh) * 2016-08-31 2020-04-01 宣捷細胞生物製藥股份有限公司 區別間質幹細胞的方法及測定間質幹細胞的純度的方法
CN106265745A (zh) * 2016-09-30 2017-01-04 广州赛莱拉干细胞科技股份有限公司 一种干细胞制剂及其在制备治疗慢性肾炎的药物中的应用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
EP4146787A4 (en) 2020-05-08 2024-06-26 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
CN117871216B (zh) * 2024-03-12 2024-06-04 中日友好医院(中日友好临床医学研究所) 一种石蜡标本中肾小球裂隙膜的三维可视化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4085410B2 (ja) * 2003-03-14 2008-05-14 株式会社 バイオリンクインク 腎臓幹細胞／前駆細胞、腎臓幹細胞／前駆細胞の分離方法、及び腎疾患の治療方法
ITFI20060099A1 (it) * 2006-04-28 2007-10-29 Azienda Ospedaliera Careggi Popolazione di cellule staminali renali, sua identificazione ed uso per finalita' terapeutiche
ES2432395T3 (es) * 2006-10-12 2013-12-03 Ethicon, Inc. Células derivadas de riñon y metodo de uso en la reparación y regeneración tisular

Also Published As

Publication number Publication date
US20110256111A1 (en) 2011-10-20
CN102292434A (zh) 2011-12-21
EP2186883A1 (en) 2010-05-19
US9499796B2 (en) 2016-11-22
ES2580172T3 (es) 2016-08-19
CN102292434B (zh) 2014-03-12
EP2361303B1 (en) 2016-04-06
JP2012507304A (ja) 2012-03-29
WO2010052192A1 (en) 2010-05-14
EP2361303A1 (en) 2011-08-31
EP2361303B8 (en) 2016-08-10
JP5795737B2 (ja) 2015-10-14

Similar Documents

Publication Publication Date Title
PL2361303T3 (pl) Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki
IL283597A (en) A pluripotent stem cell growth medium containing human serum and without a nutrient layer
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
WO2010111409A3 (en) Pluripotent stem cells
GB0907978D0 (en) Multipotent adult stem cell population
PL2495302T3 (pl) Urządzenie biologiczne do ekstrakcji krwiotwórczych komórek macierzystych i mezenchymalnych komórek macierzystych z krwi obwodowej
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
WO2009092005A3 (en) Methods of generating cardiomyocytes and cardiac progenitors and compositions
IL202401A0 (en) Methods for production and uses of multipotent cell populations, pluripotent cell populations, differentiated cell populations, and hiv -resistant cell populations
WO2011139688A3 (en) Methods for generating cardiomyocytes
WO2013070881A8 (en) Method for elimination of space through tissue approximation
WO2011024172A3 (en) Liposomal compositions and uses of same
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
WO2010014949A3 (en) Compositions comprising hepatocyte-like cells and uses thereof
ZA201200167B (en) Methods of generating hybrid/chimeric cells, and uses thereof
WO2011032025A3 (en) Adipose-derived induced pluripotent stem cells
GB0918615D0 (en) Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
ZA201201011B (en) Process for preparing levosimendan and intermediates for use in the process
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
PH12012500315A1 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same
GB2458429B (en) Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells
WO2012058291A3 (en) Methods and compositions for differentiating embryonic stem cells
WO2010065776A3 (en) Identification of neuroprotective agents using pro-inflammatory human glial cells
HK1154890A (en) Multipotent stem cell cultures
GB0906992D0 (en) Cells, preparation, uses, methods and components